About Camlin Fine Sciences
Camlin Fine Sciences is a company based in Mumbai (India) founded in 1931. The company has 1,440 employees as of March 31, 2024. Camlin Fine Sciences has completed 2 acquisitions, including Dresen and Vinpai. Camlin Fine Sciences offers products and services including Xtendra, Nasure, Ezential, adorr, and Dinamic.
- Headquarter Mumbai, India
- Employees 1440 as on 31 Mar, 2024
- Stage Public
-
Sectors
Chemicals & Materials
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Camlin Fine Sciences Limited
-
Annual Revenue
$194.39 M (USD)14.52as on Mar 31, 2024
-
Net Profit
-$16.24 M (USD)-49.91as on Mar 31, 2024
-
EBITDA
$24.88 M (USD)12.85as on Mar 31, 2024
-
Latest Funding Round
$18.82 M (USD), Post-IPO
Feb 24, 2022
-
Investors
Infinity Direct Holdings
& 1 more
-
Employee Count
1440
as on Mar 31, 2024
-
Investments & Acquisitions
Dresen
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Camlin Fine Sciences
Camlin Fine Sciences is a publicly listed company on the NSE with ticker symbol CAMLINFINE in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Camlin Fine Sciences
Camlin Fine Sciences offers a comprehensive portfolio of products and services, including Xtendra, Nasure, Ezential, adorr, and Dinamic.
Provides food safety and protection solutions
Offers plant-based shelf-life extension for food
Delivers functional excellence for food industry
Focuses on vanillin range for fragrances
Supplies diphenols for petrochemicals and pharmaceuticals
Produces vegan DHA for nutrition and health
People of Camlin Fine Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Camlin Fine Sciences
Investors in Camlin Fine Sciences
Camlin Fine Sciences has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Infinity Direct Holdings and Convergent Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Convergent Finance is engaged in private equity investments in India.
|
Locked | Locked | Locked |
Investor details for Camlin Fine Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Camlin Fine Sciences
Camlin Fine Sciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Dresen and Vinpai.
Investment portfolio details for Camlin Fine Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Food ingredients processing, cosmetics, and medical services are provided.
|
Locked | Locked | 2011 | Locked | |
|
Traditional antioxidants are manufactured by Dresen in Mexico City.
|
Locked | Locked | 1980 | Locked |
Complete acquisition details for Camlin Fine Sciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Camlin Fine Sciences
Detailed financials for Camlin Fine Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Camlin Fine Sciences Comparisons
Peer comparison for Camlin Fine Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Camlin Fine Sciences
Detailed competitors of Camlin Fine Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Camlin Fine Sciences
Complete news archive for Camlin Fine Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Camlin Fine Sciences
Camlin Fine Sciences was founded in 1931 and raised its 1st funding round 89 years after it was founded.
Camlin Fine Sciences is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Ashish Subhash Dandekar is the current CEO of Camlin Fine Sciences.
As of Mar 31, 2024, the latest employee count at Camlin Fine Sciences is 1,440.
Annual revenue of Camlin Fine Sciences is $194.39M as on Mar 31, 2024.
Camlin Fine Sciences (earlier Camlin Fine Chemicals) offers food grade antioxidants for the food and feed market. Camlins main products are TBHQ, BHA and ascorbyl palmitate for fats and oils. Apart, it also has a product range that includes liquid antioxidant blends (synthetics and naturals), food-grade ingredients and industrial antioxidants.
Camlin Fine Sciences offers Xtendra, Nasure, Ezential, adorr, and 2 more products and services.
Yes, Camlin Fine Sciences is publicly traded on NSE under the ticker symbol CAMLINFINE.
Camlin Fine Sciences has 2 investors. Key investors include Infinity Direct Holdings, and Convergent Finance.
The ticker symbol of Camlin Fine Sciences is CAMLINFINE on NSE.